Research

Items by Wonnacott, Susan

Up a level
Export as [feed] RSS 1.0 [feed] Atom [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Jump to: 2014 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1996 | 1995 | 1994
Number of items: 103.

2014

2012

Bennett, H. M., Lees, K., Harper, K. M., Jones, A. K., Sattelle, D. B., Wonnacott, S. and Wolstenholme, A. J., 2012. Xenopus laevis RIC-3 enhances the functional expression of the C. elegans homomeric nicotinic receptor, ACR-16, in Xenopus oocytes. Journal of Neurochemistry, 123 (6), pp. 911-918.

2011

del Barrio, L., Martin-de-Saavedra, M. D., Romero, A., Parada, E., Egea, J., Avila, J., McIntosh, J. M., Wonnacott, S. and Lopez, M. G., 2011. Neurotoxicity Induced by Okadaic Acid in the Human Neuroblastoma SH-SY5Y Line Can Be Differentially Prevented by alpha 7 and beta 2*Nicotinic Stimulation. Toxicological Sciences, 123 (1), pp. 193-205.

Glendinning, S. K., Buckingham, S. D., Sattelle, D. B., Wonnacott, S. and Wolstenholme, A. J., 2011. Glutamate-Gated Chloride Channels of Haemonchus contortus Restore Drug Sensitivity to Ivermectin Resistant Caenorhabditis elegans. PLoS ONE, 6 (7), e22390.

2010

Iturriaga-Vasquez, P., Carbone, A., Garcia-Beltran, O., Livingstone, P. D., Biggin, P. C., Cassels, B. K., Wonnacott, S., Zapata-Torres, G. and Bermudez, I., 2010. Molecular determinants for competitive inhibition of alpha 4 beta 2 nicotinic acetylcholine receptors. Molecular Pharmacology, 78 (3), pp. 366-375.

Kennett, A. F., Heal, D. and Wonnacott, S., 2010. Investigating the subtypes of nocotinic achr involved incatecholamine release in different regions of the rodent brain. Journal of Psychopharmacology, 24 (Supplement 3), A32.

Wonnacott, S. and Livingstone, P. D., 2010. Nicotinic receptors and the modulation of transmitter release in the prefrontal cortex. European Neuropsychopharmacology, 20 (Supplement 3), S193.

Araud, T., Wonnacott, S. and Bertrand, D., 2010. Associated proteins: the universal toolbox controlling ligand gated ion channel function. Biochemical Pharmacology, 80 (2), pp. 160-169.

Abin-Carriquiry, J. A., Zunini, M. P., Cassels, B. K., Wonnacott, S. and Dajas, F., 2010. In silico characterization of cytisinoids docked into an acetylcholine binding protein. Bioorganic & Medicinal Chemistry Letters, 20 (12), pp. 3683-3687.

Livingstone, P. D., Dickinson, J. A., Srinivasan, J., Kew, J. N. C. and Wonnacott, S., 2010. Glutamate-Dopamine Crosstalk in the Rat Prefrontal Cortex is Modulated by Alpha7 Nicotinic Receptors and Potentiated by PNU-120596. Journal of Molecular Neuroscience, 40 (1-2), pp. 172-176.

Abin-Carriquiry, J. A., Urbanavicius, J., Scorza, C., Rebolledo-Fuentes, M., Wonnacott, S., Cassels, B. K. and Dajas, F., 2010. Increase in locomotor activity after acute administration of the nicotinic receptor agonist 3-bromocytisine in rats. European Journal of Pharmacology, 634 (1-3), pp. 89-94.

Rushforth, S. L., Allison, C., Wonnacott, S. and Shoaib, M., 2010. Subtype-selective nicotinic agonists enhance olfactory working memory in normal rats: A novel use of the odour span task. Neuroscience Letters, 471 (2), pp. 114-118.

2009

Quarta, D., Naylor, C. G., Barik, J., Fernandes, C., Wonnacott, S. and Stolerman, I. P., 2009. Drug discrimination and neurochemical studies in alpha 7 null mutant mice: tests for the role of nicotinic alpha 7 receptors in dopamine release. Psychopharmacology, 203 (2), pp. 399-410.

Livingstone, P. D., Srinivasan, J., Kew, J. N. C., Dawson, L. A., Gotti, C., Moretti, M., Shoaib, M. and Wonnacott, S., 2009. α7 and non-α7 nicotinic acetylcholine receptors modulate dopamine release in vitro and in vivo in the rat prefrontal cortex. European Journal of Neuroscience, 29 (3), pp. 539-550.

Barik, J. and Wonnacott, S., 2009. Molecular and cellular mechanisms of action of nicotine in the CNS. In: Henningfield, J. E., London, E. D. and Pogun, S., eds. Nicotine Psychopharmacology. Vol. 192. Berlin: Springer, pp. 173-207. (Handbook of Experimental Pharmacology)

2008

Innocent, N., Livingstone, P. D., Hone, A., Kimura, A., Young, T., Whiteaker, P., McIntosh, J. M. and Wonnacott, S., 2008. Aplha-Conotoxin Arenatus IB[V11L,V16D] Is a Potent and Selective Antagonist at Rat and Human Native 7 Nicotinic Acetylcholine Receptors. Journal of Pharmacology and Experimental Therapeutics, 327 (2), pp. 529-537.

Abin-Carriquiry, J., Costa, G., Urbanavicius, J., Cassels, B., Rebolledo-Fuentes, M., Wonnacott, S. and Dajas, F., 2008. In vivo modulation of dopaminergic nigrostriatal pathways by cytisine derivatives: Implications for Parkinson's Disease. European Journal of Pharmacology, 589 (1-3), pp. 80-84.

Wonnacott, S., 2008. Smoking cessation 2008. IDrugs, 11 (4), pp. 256-259.

Hanrott, K., Murray, T. K., Orfali, Z., Ward, M., Finlay, C., O'Neill, M. J. and Wonnacott, S., 2008. Differential activation of PKCδ in the substantia nigra of rats following striatal or nigral 6-hydroxydopamine lesions. European Journal of Neuroscience, 27 (5), pp. 1086-1096.

2007

Oliver, J. L., Pashmi, G., Barnett, P., Mettens, P., Biemans, R., Monteyne, P., Palmantier, R., Gallagher, T., Ramaya, S. and Wonnacott, S., 2007. Development of an anti-cotinine vaccine to potentiate nicotine-based smoking cessation strategies. Vaccine, 25 (42), pp. 7354-7362.

Urbanavicius, J., Margot, F., Costa, G., Abin, J.-A., Wonnacott, S. and Dajas, F., 2007. Intermittent nicotine administration selectively induced tyrosine hydroxylase plasticity in the neurodegenerating striatum. Journal of Neurochemistry, 102 (3), pp. 723-730.

Dickinson, J. A., Hanrott, K. E., Mok, M. H. S., Kew, J. N. C. and Wonnacott, S., 2007. Differential coupling of alpha 7 and non-alpha 7 nicotinic acetylcholine receptors to calcium-induced calcium release and voltage-operated calcium channels in PC12 cells. Journal of Neurochemistry, 100 (4), pp. 1089-1096.

Nuutinen, S., Barik, J., Jones, I. W. and Wonnacott, S., 2007. Differential effects of acute and chronic nicotine on Elk-I in rat hippocampus. Neuroreport, 18 (2), pp. 121-126.

Sidhpura, N., Redfern, P., Rowley, H., Heal, D. and Wonnacott, S., 2007. Comparison of the effects of bupropion and nicotine on locomotor activation and dopamine release in vivo. Biochemical Pharmacology, 74 (8), pp. 1292-1298.

Wonnacott, S. and Barik, J., 2007. Nicotinic ACh Receptors. Tocris Reviews, 28.

2006

Kanakubo, A., Gray, D., Innocent, N., Wonnacott, S. and Gallagher, T., 2006. The synthesis and nicotinic binding activity of (+/-)-epiquinamide and (+/-)C(1)-epiepiquinamide. Bioorganic & Medicinal Chemistry Letters, 16 (17), pp. 4648-4651.

Abin-Carriquiry, J. A., Voutilainen, M. H., Barik, J., Cassels, B. K., Iturriaga-Vasquez, P., Bermudez, I., Durand, C., Dajas, F. and Wonnacott, S., 2006. C3-halogenation of cytisine generates potent and efficacious nicotinic receptor agonists. European Journal of Pharmacology, 536 (1-2), pp. 1-11.

Hanrott, K., Gudmunsen, L., O'Neill, M. J. and Wonnacott, S., 2006. d6-Hydroxydopamine- induced apoptosis is mediated via extracellular auto-oxidation and caspase 3-dependent activation of protein kinase C delta. Journal of Biological Chemistry, 281 (9), pp. 5373-5382.

Wonnacott, S., Barik, J., Dickinson, J. and Jones, I. W., 2006. Nicotinic receptors modulate transmitter cross talk in the CNS. Journal of Molecular Neuroscience, 30 (1-2), pp. 137-140.

Jones, I. W., Westmacott, A., Chan, E., Jones, R. W., Dineley, K., O'Neill, M. J. and Wonnacott, S., 2006. alpha 7 nicotinic acetylcholine receptor expression in Alzheimer's disease - Receptor densities in brain regions of the APP((SWE)) mouse model and in human peripheral blood lymphocytes. Journal of Molecular Neuroscience, 30 (1-2), pp. 83-84.

2005

Cassels, B. K., Bermudez, I., Dajas, F., Abin-Carriquiry, J. A. and Wonnacott, S., 2005. From ligand design to therapeutic efficacy: the challenge for nicotinic receptor research. Drug Discovery Today, 10 (23-24), pp. 1657-1665.

Barik, J., Dajas-Bailador, F. and Wonnacott, S., 2005. Cellular responses to nicotinic receptor activation are decreased after prolonged exposure to galantamine in human neuroblastoma cells. British Journal of Pharmacology, 145 (8), pp. 1084-1092.

Abin-Carriquiry, J. A., Iturriaga-Vasquez, P., Costa, G., Urbanavicius, J., Ferreira, M., Cassels, B., Wonnacott, S. and Dajas, F., 2005. Cytisine and derivatives partially prevents the striatal dopamine decrease in an experimental model of Parkinson's disease. Journal of Neurochemistry, 94 (Supplement 2), p. 47.

Jones, I. W. and Wonnacott, S., 2005. Why doesn't nicotinic ACh receptor immunoreactivity knock out? Trends in Neurosciences, 28 (7), pp. 343-345.

Wonnacott, S., Sidhpura, N. and Balfour, D. J. K., 2005. Nicotine: from molecular mechanisms to behaviour. Current Opinion in Pharmacology, 5 (1), pp. 53-59.

2004

Mogg, A. J., Jones, F. A., Pullar, I. A., Sharples, C. G. V. and Wonnacott, S., 2004. Functional responses and subunit composition of presynaptic nicotinic receptor subtypes explored using the novel agonist 5-iodo-A-85380. Neuropharmacology, 47 (6), pp. 848-859.

Dajas-Bailador, F. and Wonnacott, S., 2004. Nicotinic acetylcholine receptors and the regulation of neuronal signalling. Trends in Pharmacological Sciences, 25 (6), pp. 317-324.

Nicke, A., Wonnacott, S. and Lewis, R. J., 2004. alpha-Conotoxins as tools for the elucidation of structure and function of neuronal nicotinic acetylcholine receptor subtypes. European Journal of Biochemistry, 271 (12), pp. 2305-2319.

Sidhpura, N., Rowley, H. L., Heal, D. J., Mitchell, P. J., Redfern, P. H. and Wonnacott, S., 2004. Neurochemical interactions of nicotine and bupropion in the rat striatum. Journal of Psychopharmacology, 18 (3), A31.

2003

Karig, G., Large, J. M., Sharples, C. G. V., Sutherland, A., Gallagher, T. and Wonnacott, S., 2003. Synthesis and nicotinic binding of novel phenyl derivatives of UB-165. Identifying factors associated with alpha 7 selectivity. Bioorganic & Medicinal Chemistry Letters, 13 (17), pp. 2825-2828.

Hahn, B., Sharples, C. G. V., Wonnacott, S., Shoaib, M. and Stolerman, P., 2003. Attentional effects of nicotinic agonists in rats. Neuropharmacology, 44 (8), pp. 1054-1067.

Richardson, C. E., Morgan, J. M., Jasani, B., Green, J. T., Rhodes, J., Williams, G. T., Lindstrom, J., Wonnacott, S., Peel, S. and Thomas, G. A. O., 2003. Effect of smoking and transdermal nicotine on colonic nicotinic acetylcholine receptors in ulcerative colitis. QJM: An International Journal of Medicine, 96 (1), pp. 57-65.

Pashmi, G., Barnett, P., Mettens, P., Gallagher, T. and Wonnacott, S., 2003. Immunotherapy approach targeting cotinine, the major metabolite of nicotine, to combat nicotine addiction. Society for Neuroscience Abstracts, 2003, 322.2.

Sutherland, A., Gallagher, T., Sharples, C. G. V. and Wonnacott, S., 2003. Synthesis of two fluoro analogues of the nicotinic acetylcholine receptor agonist UB-165. Journal of Organic Chemistry, 68 (6), pp. 2475-2478.

2002

Wonnacott, S. and Mogg, A., 2002. Chronic nicotine treatment and nicotinic receptor function. European Neuropsychopharmacology, 12 (Supplement 3), S87-S88.

Mogg, A. J., Whiteaker, P., McIntosh, J. M., Marks, M., Collins, A. C. and Wonnacott, S., 2002. Methyllycaconitine is a potent antagonist of alpha-conotoxin-MII-sensitive presynaptic nicotinic acetylcholine receptors in rat striatum. Journal of Pharmacology and Experimental Therapeutics, 302 (1), pp. 197-204.

Sidhpura, N., Kenyon, R., Redfern, P. and Wonnacott, S., 2002. Actions of bupropion on nicotine-evoked dopamine release in rat striatum. Behavioural Pharmacology, 13 (5-6), pp. 503-504.

Jones, I. W., Bolam, J. P. and Wonnacott, S., 2002. Localization of neuronal nicotinic acetylcholine receptor subunits in rat substantia nigra and dorsal striatum. In: Nicholson, L. F. B. and Faull, R. L., eds. Basal Gangia VII. Plenum Press, New York, pp. 127-136.

Sharples, C. G. V., Karig, G., Simpson, G. L., Spencer, J. A., Wright, E., Millar, N. S., Wonnacott, S. and Gallagher, T., 2002. Synthesis and pharmacological characterization of novel analogues of the nicotinic acetylcholine receptor agonist (+/-)-UB-165. Journal of Medicinal Chemistry, 45 (15), pp. 3235-3245.

Da Cunha, C., Angelucci, M. E. M., Canteras, N. S., Wonnacott, S. and Takahashi, R. N., 2002. The lesion of the rat substantia nigra pars compacta dopaminergic neurons as a model for Parkinson's disease memory disabilities. Cellular and Molecular Neurobiology, 22 (3), pp. 227-237.

2001

Wonnacott, S., Mogg, A., Bradly, A. and Jones, I. W., 2001. Presynaptic nicotinic acetylcholine receptors: subtypes mediating neurotransmitter release. In: Levin, E. D., ed. Nicotine Receptors in the Nervous System. CRC Press, pp. 29-50.

Hodgson, D. M., Maxwell, C. R., Wisedale, R., Matthews, I. R., Carpenter, K. J., Dickenson, A. H. and Wonnacott, S., 2001. 6-Substituted 2-azabicyclo[2.2.1]hept-5-enes by nitrogen-directed radical rearrangement: Synthesis of an epibatidine analogue with high binding affinity at the nicotinic acetylcholine receptor. Journal of the Chemical Society: Perkin Transactions 1

Sharples, C. G. V., Jones, I. W., Millar, N., Karig, G., Gallagher, T. and Wonnacott, S., 2001. Characterisation of UB-165 analogues at the alpha3beta4 nicotinic acetylcholine receptor. Society for Neuroscience Abstracts, 27 (1), p. 1276.

Dajas-Bailador, F. A., Mogg, A. and Wonnacott, S., 2001. Contribution of intracellular stores to the increase in cytoplasmic calcium after nAChR activation in SH-SY5Y cells. Society for Neuroscience Abstracts, 27 (1), p. 987.

Richardson, C. E., Morgan, J. M., Jasani, B., Green, J. T., Rhodes, J., Williams, G. T., Lindstrom, J., Wonnacott, S., Thomas, G. A. O. and Smith, V., 2001. Megacystis-microcolon-intestinal hypoperistalsis syndrome and the absence of the alpha 3 nicotinic acetylcholine receptor subunit. Gastroenterology, 121 (2), pp. 350-357.

Sharples, C. G. V. and Wonnacott, S., 2001. Neuronal nicotinic receptors. Tocris Reviews, 19.

Bradly, A. L., Jones, I. W. and Wonnacott, S., 2001. Ultrastructural localisation of neuronal nicotinic acetylcholine receptor alpha4 subunit in rat nigro-striatal neurons. Society for Neuroscience Abstracts, 27 (1), p. 980.

Lind, R. J., Hardick, D. J., Blagbrough, I. S., Potter, B. V. L., Wolstenholme, A. J., Davies, A. R. L., Clough, M. S., Earley, F. G. P., Reynolds, S. E. and Wonnacott, S., 2001. [3H]-methyllycaconitine : a high affinity radioligand that labels invertebrate nicotinic acetylcholine receptors. Insect Biochemistry and Molecular Biology, 31 (6-7), pp. 533-542.

2000

Wonnacott, S., Kaiser, S., Mogg, A., Soliakov, L. and Jones, I. W., 2000. Presynaptic nicotinic receptors modulating dopamine release in the rat striatum. European Journal of Pharmacology, 393 (1-3), pp. 51-58.

Soliakov, L., Dajas-Bailador, F. and Wonnacott, S., 2000. NAChR-induced activation of MAPK (ERK1/2) in the human neuroblastoma SH-SY5Y cells. European Journal of Neuroscience, 12 (Supplement), p. 35.

Sharples, C. G. V., Kaiser, S., Soliakov, L., Marks, M. J., Collins, A. C., Washburn, M., Wright, E., Spencer, J. A., Gallagher, T., Whiteaker, P. and Wonnacott, S., 2000. UB-165: A novel nicotinic agonist with subtype selectivity implicates the alpha 4 beta 2*subtype in the modulation of dopamine release from rat striatal synaptosomes. Journal of Neuroscience, 20 (8), pp. 2783-2791.

Jones, I. W., Bolam, J. P. and Wonnacott, S., 2000. Ultrastructural localisation of neuronal nicotinic acetylcholine receptor beta 2 subunit and tyrosine hydroxylase in rat striatum. European Journal of Neuroscience, 12 (Supplement), p. 35.

1999

Whiteaker, P., Davies, A. R. L., Marks, M. J., Blagbrough, I. S., Potter, B. V. L., Wolstenholme, A. J., Collins, A. C. and Wonnacott, S., 1999. An autoradiographic study of the distribution of binding sites for the novel ∝7-selective nicotinic radioligand [3H]-methyllycaconitine in the mouse brain. European Journal of Neuroscience, 11 (8), pp. 2689-2696.

1998

1996

Wonnacott, S., Soliakov, L., Wilkie, G., Redfern, P. and Marshall, D., 1996. Presynaptic nicotinic acetylcholine receptors in the brain. Drug Development Research, 38 (3-4), pp. 149-159.

Marshall, D., Soliakov, L., Redfern, P. and Wonnacott, S., 1996. Tetrodotoxin-sensitivity of nicotine-evoked dopamine release from rat striatum. Neuropharmacology, 35 (11), pp. 1531-1536.

1995

1994

Blagbrough, I. S., Coates, P. A., Hardick, D. J., Lewis, T., Rowan, M. G., Wonnacott, S. and Potter, B. V. L., 1994. Acylation of lycoctonine : semi-synthesis of inuline, delsemine analogues and methyllycaconitine. Tetrahedron Letters, 35 (46), pp. 8705-8708.

Blagbrough, I. S., Hardick, D. J., Wonnacott, S. and Potter, B. V. L., 1994. Regioselective demethylation of aconitine. Tetrahedron Letters, 35 (20), pp. 3367-3370.

This list was generated on Fri Jul 31 04:08:31 2015 IST.